Susan Hasty, Publisher
Table of Contents . . . April 4th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
End-stage Heart Failure - Antisense control of phospholamban expression restores cardiac response
Tumor Targeting - T cells used to deliver toxic fusion proteins directly to tumors
Acute Renal Failure - Hepatocyte growth factor DNA stems kidney disease in murine model
Muscular Dystrophy - New gene therapy trials planned
Ocular Inflammation - Topical agent controls herpetic lesions by extinguishing neovascularization
Vascular Gene Delivery - Percutaneous method, smaller volume increase agent retention in heart
Angiogenic Gene Therapy - American Heart Association issues results from Generx trial for stable angina
Cancer Therapy - Remedyne announces a license agreement for development of a cancer immunotherapeutic
Finance - Paradigm announces that 2001 revenues increased 137%
Genotyping - New data demonstrate accuracy and reliability of Trugene HIV resistance test
Hemophilia - Gene therapy may help to improve blood clotting for bleeding disorder
Human Antibody Therapeutics - Genetastix announces research collaboration
Information Technology - OmniViz to provide integrated analysis of Affymetrix array data
Neurodegenerative Diseases - Researcher sees promise in use of stem cells for brain repair
Neurological Disorders - Gemin X Biotechnologies enters drug discovery partnership
Therapeutic Cloning - Scientists combine embryonic stem cells, gene therapy in mouse research
mRNA Isolation - Sequitur launches of mRNA catcher
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.